Business Description
IsoPlexis Corp
NAICS : 339112
SIC : 3845
Description
IsoPlexis Corp is a developer of a single-cell detection system designed to accelerate insights in the field of cancer. It designed a platform to reveal functional protein biology and cellular signaling networks at single-cell resolution to accelerate the development of advanced medicines.
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.73 | |||||
Equity-to-Asset | 0.38 | |||||
Debt-to-Equity | 1.25 | |||||
Debt-to-EBITDA | -0.54 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -5.11 | |||||
Beneish M-Score | -8.29 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 30.2 | |||||
3-Year EBITDA Growth Rate | -93.1 | |||||
3-Year EPS without NRI Growth Rate | -90.8 | |||||
3-Year FCF Growth Rate | -82 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | -42.53 | |||||
12-1 Month Momentum % | -72.53 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.06 | |||||
Quick Ratio | 2.5 | |||||
Cash Ratio | 2.12 | |||||
Days Inventory | 675.04 | |||||
Days Sales Outstanding | 89.69 | |||||
Days Payable | 107.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.7 | |||||
Shareholder Yield % | -33.5 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -5.52 | |||||
Operating Margin % | -575.68 | |||||
Net Margin % | -632.41 | |||||
FCF Margin % | -623.21 | |||||
ROE % | -114.64 | |||||
ROA % | -69.69 | |||||
ROIC % | -147.29 | |||||
ROC (Joel Greenblatt) % | -251.9 | |||||
ROCE % | -73.08 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.78 | |||||
PB Ratio | 0.73 | |||||
Price-to-Tangible-Book | 1.41 | |||||
EV-to-EBIT | -0.44 | |||||
EV-to-EBITDA | -0.46 | |||||
EV-to-Revenue | 2.65 | |||||
EV-to-FCF | -0.43 | |||||
Price-to-Net-Current-Asset-Value | 7.62 | |||||
Earnings Yield (Greenblatt) % | -227.27 | |||||
FCF Yield % | -348.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ISO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IsoPlexis Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 16.761 | ||
EPS (TTM) ($) | -2.7 | ||
Beta | 0 | ||
Volatility % | 90.91 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0.067114 | ||
20-Day SMA ($) | 0 | ||
12-1 Month Momentum % | -72.53 | ||
52-Week Range ($) | 0.6001 - 4 | ||
Shares Outstanding (Mil) | 39.76 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
IsoPlexis Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
IsoPlexis Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
IsoPlexis Corp Frequently Asked Questions
What is IsoPlexis Corp(ISO)'s stock price today?
The current price of ISO is $0.76. The 52 week high of ISO is $4.00 and 52 week low is $0.60.
When is next earnings date of IsoPlexis Corp(ISO)?
The next earnings date of IsoPlexis Corp(ISO) is 2024-11-10 Est..
Does IsoPlexis Corp(ISO) pay dividends? If so, how much?
IsoPlexis Corp(ISO) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |